Alcohol consumption and risk of deep venous thrombosis and pulmonary embolism in older persons

Journal of the American Geriatrics Society

Volumn 44, Issue 9, 1996, Pages 1030-1037

  Pahor, Marco ^a,e   Guralnik, Jack M ^b   Havlik, Richard J ^b   Carbonin, Pierugo ^a   Salive, Marcel E ^b   Ferrucci, Luigi ^c   Corti, Maria Chiara ^b   Hennekens, Charles H ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c INRCA   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; AGED; AGING; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BODY MASS; COGNITION; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS;

EID: 0029811015     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb02933.x     Document Type: Article

References (61)

1. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA 1986;256:744-749.
2. Lilienfeld DE, Godbold JH. Geographic distribution of pulmonary embolism mortality rates in the United States, 1980 to 1984. Am Heart J 1992;124:1068-1072.
3. Goldhaber SZ, Hennekens CH. Time trends in hospital mortality and diagnosis of pulmonary embolism. Am Heart J 1982;104:305-306.
4. Gillum RF. Pulmonary embolism and thrombophlebitis in the United States, 1970-1985. Am Heart J 1987;114:1262-1264.
5. Carson JL, Kelley MA, Duff A et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-1245.
6. Goldhaber SZ, Savage DD, Garrison RJ et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983;74:1023-1028.
7. Gaziano JM, Buring JE, Breslow JI. et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-1834.
8. Stampfer MJ, Colditz GA, Willett WC et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267-273.
9. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994;272:929-933.
10. Jakubowski JA, Vaillancourt R, Deykin D. Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro. Arteriosclerosis 1988;8:436-441.
11. Pikaar NA, Wedel M, van der Beek FJ et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism 1987;36:538-543.
12. Renaud SC, Beswick AD, Fehily AM et al. Alcohol and platelet aggregation: The Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992;55:1012-1017.
13. Cornoni-Huntley J, Ostfeld AM, Taylor JO et al. Established Populations for Epidemiologic Studies of the Elderly: Study design and methodology. Aging Clin Exp Res 1993;5:27-37.
14. Pahor M, Guralnik JM, Salive MF et al. Physical activity and risk of severe gastrointestinal hemorrhage in older persons. JAMA 1994;272:595-599.
15. Pahor M, Guralnik JM, Salive ME et al. Disability and severe gastrointestinal hemorrhage. A prospective study of community-dwelling older persons. J Am Geriatr Soc 1994;42:816-825.
16. Pahor M, Guralnik JM, Furberg CD et al. Calcium antagonists increase risk of gastrointestinal hemorrhage in older persons with hypertension. Lancet 1996;347:1061-1065.
17. Pahor M, Guralnik JM, Corti C et al. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-1197.
18. International Classification of Diseases, 9th revision, Clinical Modification. 2nd Ed. Washington, DC: Public Health Service-Health Care Financing Administration, 1980.
19. Kniffin WD Jr, Baron JA, Barrett J et al. Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861-866.
20. Hennekens CH, Willett W, Rosner B et al. Effects of beer, wine, and liquor in coronary deaths. JAMA 1979;242:1973-1974.
21. Rosow I, Breslau N. A Gurtman health scale for the aged. J Gerontol 1966;21:556-559.
22. Katz S, Ford AB, Moskowitz RW et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963;185:94-99.
23. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-441.
24. Pahor M, Chrischilles EA, Guralnik JM et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994;10:405-411.
25. Hypertension Detection and Follow-up Program Cooperative Group. Blood pressure studies in 14 communities; A two-stage screen for hypertension. JAMA 1977;237:2385-2391.
26. Cox DR. Regression models and life tables. J R Stat Soc 1972;34B:187-220.
27. SPSS Advanced Statistics Reference Guide, Release 6.0. Chicago: SPSS Inc., 1993.
28. Scherr PA, LaCroix AZ, Wallace RB et al. Light to moderate alcohol consumption and mortality in the elderly. J Am Geriatr Soc 1992:40:651-657.
29. Gordon T, Kannel WB. Drinking habits and cardiovascular disease: The Framingham Study. Am Heart J 1983;105:667-673.
30. Gordon T, Doyle JT. Drinking and coronary heart disease: The Albany Study. Am Heart J 1985;110:331-334.
31. Moore RD, Pearson TA. Moderate alcohol consumption and coronary artery disease. A review. Medicine (Baltimore) 1986;65:242-267.
32. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994;344:1719-1723.
33. Gill JS, Zezulka AV, Shipley MJ et al. Stroke and alcohol consumption. N Engl J Med 1986;315:1041-1046.
34. Colditz GA, Branch LG, Lipnick RJ et al. Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J 1985;109:886-889.
35. Klatsky AL, Friedman GD, Siegelaub AB. Alcohol and mortality. A ten-year Kaiser-Permanente experience. Ann Intern Med 1981;95:139-145.
36. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986;124:481-489.
37. Camargo CA Jr, Gaziano JM, Hennekens CH et al. Prospective study of moderate alcohol consumption and mortality in male physicians. Circulation 1994(abstract);90:1-341.
38. Ridker PM, Vaughan DE, Stampfer MJ et al. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasmihnogen activator and plasminogen activator inhibitor. Circulation 1992;85:1822-1827.
39. Anderson FA, Jr, Wheeler HB, Goldberg RJ et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-938.
40. U.S. Department of Health and Human Services. Vital and Health Statistics. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990. Hyattsville, MD: Public Health Service, Centers for Disease Control, 1992.
41. Karwinski B, Svendsen E, Seim S. Pulmonary embolism and heart disease. An autopsy study. Pathol Res Pract 1993;189:1058-1062.
42. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Principles and Quantitative Methods. Belmont, CA: Lifetime Learning Publications, Wadsworth Inc., 1982.
43. Willett WC, Stampfer MJ, Colditz GA. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 1987;316:1174-1180.
44. Hirsh J. Pulmonary embolism in the elderly. Cardiol Clin 1991;9:457-474.
45. Latham B, Kafoy EA, Barrett O Jr, Gonzalez MF. Deficient tissue plasminogen activator release and normal tissue plasminogen activator inhibitor in a patient with recurrent deep vein thrombosis. Am J Med 1990;88:199-200.
46. Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) 1985;290:1453-1456.
47. Paramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor - Relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemost 1985;54:713-716.
48. Engesser L, Brommer EJ, Kluft C, Briet E. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic venous thrombophilia. Thromb Haemost 1989;62:673-680.
49. Tabernero MD, Estelles A, Vicente V et al. Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism. Thromb Res 1989;56:565-570.
50. Juhan-Vague I, Valadier J, Alessi MC et al. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987;57:67-72.
51. Hedner U, Tengborn L. Characterizing hereditary and acquired defects of plasminogen. Haemostasis 1988;18 (Suppl 1):87-92.
52. Ridker PM, Hennekens CH, Stampfer MJ et al. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994;343:940-943.
53. Ridker PM, Vaughan DE, Stampfer MJ et al. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165-1168.
54. Hendriks HF, Veenstra J, Velthuis-te Wierik EJ et al. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br Med J 1994;308:1003-1006.
55. Collaborative overview of randomised trials of antiplatelet therapy-III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. Br Med J 1994;308:235-246.
56. Belcaro G, Errichi BM, De Simone P. Prevention of recurrent deep venous thrombosis with indobufen. A 3-year follow-up study using color duplex scanning. Angiology 1993;44:328-331.
57. Herbert JM, Bernat A, Maffrand JP. Importance of platelets in experimental venous thrombosis in the rat. Blood 1992;80:2281-2286.
58. Landolfi R, Steiner M. Ethanol raises prostacyclin in vivo and in vitro. Blood 1984;64:679-682.
59. Toivanen J, Ylikorkala O, Viinikka L. Ethanol inhibits platelet thromboxane A2 production but has no effect on lung prostacyclin synthesis in humans. Thromb Res 1984;33:1-8.
60. Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA 1986;255:2311-2314.
61. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown and Co., 1987.